The cascade of amyloid formation relates to multiple complex events at the molecular level.
Previous research has established amyloid plaque deposition as the leading cause of …

Alzheimer's disease (AD) is a progressive multifaceted neurodegenerative disease and
remains a formidable global health challenge. The current medication for AD gives …

Macrophages restrict bacterial infection partly by stimulating phagocytosis and partly by
stimulating release of cytokines and complement components. Here, we treat macrophages …

Amyloid plaque formation in the brain is mainly responsible for the onset of Alzheimer's
disease (AD). Structure-based peptides have gained importance in recent years, and …

Copper has been widely used in bacteriostatic materials and pesticides, which make it as a
potential threat for human health. The development of an electrochemical sensor with high …

Alzheimer's disease (AD) is the most prevalent neurodegenerative dementia, marked by
progressive cognitive decline and memory impairment. Despite advances in therapeutic …

Amyloid beta (Aβ) aggregation is one of the distinctive pathological hallmarks of Alzheimer's
disease (AD). Therefore, the development of effective inhibitors against Aβ aggregate …

Peptides possess a remarkable propensity to adopt distinct morphologies, ranging from
simple aggregates to complex structures such as fibrils and nanotubes. Morphology …

Background Alzheimer's disease (AD) is a complex neurodegenerative disorder, with recent
research emphasizing the roles of microglia and their secreted extracellular vesicles in AD …

Aberrant protein misfolding and accumulation is considered to be a major pathological pillar
of neurodegenerative disorders, including Alzheimer's and Parkinson's diseases …